email article The FDA cleared the Bigfoot Unity diabetes management system, used in conjunction with Abbott's FreeStyle Libre 2 system, for type 1 and 2 diabetes; the system translates continuously monitored glucose data into on-demand insulin dosing recommendations shown on the pen-cap screen. Novo Nordisk issued a nationwide voluntary recall of several batches of its insulin product samples -- Levemir, Tresiba, Fiasp, Novolog, and Xultophy -- due to improper temperature storage. Not only has 2.4 mg of injectable semaglutide demonstrated efficacy for weight loss, but it also may help dampen appetite, food cravings, and calorie intake, according to a study presented at the European Congress on Obesity. (